Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Randomized trials comparing multi-vessel percutaneous coronary intervention to coronary artery bypass grafting (CABG) have demonstrated the long-term superiority of CABG in diabetic patients. Benefits include improved survival, fewer recurrent myocardial infarctions and a lower risk of the need for repeat intervention. The focus of this review article is to review the contemporary management of diabetic patients with multi-vessel coronary artery disease.

Type

Journal article

Journal

Curr Pharm Des

Publication Date

2014

Volume

20

Pages

4589 - 4596

Keywords

Coronary Artery Bypass, Coronary Artery Disease, Diabetic Angiopathies, Humans, Myocardial Infarction, Myocardial Revascularization, Percutaneous Coronary Intervention, Randomized Controlled Trials as Topic, Reoperation, Survival